0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Exhibition > bioSeedin webinar - Enabling tools to accelerate development of SARS-CoV-2 therapy
  1. bioSeedin webinar - Enabling tools to accelerate development of SARS-CoV-2 therapy

  2. Saturday, May 23, 2020 5:30 to 7:00pm PT
  3. Online
  4. Yinan Jiang,Ph.D. (Product Development Manager ACROBiosystems), Henry Ji, Ph.D. (Co-founder, CEO&President Sorrento Therapeutics)
  5. Free Registration
  6. Topic:  Enabling tools to accelerate development of SARS-CoV-2 therapy

    Time:  Saturday, May 23, 2020 5:30 to 7:00pm PT

    This webinar will cover:

    > The molecular mechanism of SARS-CoV-2 spike protein-mediated virus entry into host cell.

    > The important role of SARS-CoV-2 spike protein in serological testing, vaccine and antibody therapeutics development for COVID-19.

    > The 3-D structural studies of SARS-CoV-2 spike protein alone or in complex with antibodies.

    > The characterization of SARS-CoV-2 spike protein glycosylation sites.

    > The discoveries of mutations in RBD of SARS-CoV-2 spike protein and the implications for drug and vaccine design.


    Organizers:SABPA (Sino-American Biotechnology and Pharmaceutical Professional Association) , ACROBIOSYSTEMS

    17:30-17:35

    Welcome to SABPA FTD Webinar, Hua Gong, Ph.D., SABPA FTD


    17:35-18:05

    Sorrento's approach to prevention and therapeutic intervention of COVID-19 Pandemic. Henry Ji, Ph.D., Sorrento Therapeutics


    18:05-18:35

    Critical role of SARS-CoV-2 Spike protein in developing drugs,serological tests and vaccines for COVID-19. Yinan Jiang, Ph.D.ACROBiosystems


    18:35-19:00

    Q&A,Moderators:Howard Pan, Hui Wang and Andrew Wang,SABPA FTD


    1590118504140036.jpg

New & Hot Products


This web search service is supported by Google Inc.

totop